Mogamulizumab

Definition: Mogamulizumab, sold under the brand name Poteligeo, is a humanized, afucosylated monoclonal antibody targeting CC chemokine receptor type 4 (CCR4). It is given by injection into a vein. The most common side effects include rash, infusion-related reactions, fatigue, diarrhea, musculoskeletal pain, and upper respiratory tract infection. source: Wikipedia

ID

773522000

ID date

8 Sep 2021

Previous ID

38162411000001105

Name

Mogamulizumab